Psychiatric disorders exhibit an enormous burden on the health care systems worldwide
accounting for around one-third of years lost due to disability among adults. Their etiology is …

Psychiatric disorders affect millions of individuals and their families worldwide, and the costs
to society are substantial and are expected to rise due to a lack of effective treatments …

Ayahuasca is a natural psychoactive brew, used in traditional ceremonies in the Amazon
basin. Recent research has indicated that ayahuasca is pharmacologically safe and its use …

Schizophrenia patients show signs of accelerated aging in cognitive and physiological
domains. Both schizophrenia and accelerated aging, as measured by MRI brain images and …

Respiratory and emotional responses to blood-acidifying inhalation of CO2 are markers of
some human anxiety disorders, and can be enhanced by repeatedly cross-fostering (RCF) …

Schizophrenia is a complex mental disorder whose causes are still far from being known.
Although researchers have focused on genetic or environmental contributions to the …

Background Transcriptomic profile differences between patients with bipolar disorder and
healthy controls can be identified using machine learning and can provide information about …

Schizophrenia is a complex psychiatric disorder characterised by the presence of positive,
negative and cognitive symptoms that lack a unifying neuropathology. The absence of …

Objective Complex machine learning classification algorithms using transcriptome data from
post-mortem cerebellar tissue of bipolar patients and unaffected controls, have been …

Schizophrenia refers to a complex psychiatric illness characterized by the heterogenic
presence of positive, negative and cognitive symptoms occurring in all human societies. The …